Nagoya University · Medicine
Professor Toshiya Inada's research lab specializes in psychopharmacology and psychiatric genetics, focusing on the neurobiological underpinnings of schizophrenia and treatment-resistant disorders. Key research directions include psychotropic dose equivalence in clinical practice, genetic susceptibility to treatment-emergent side effects such as tardive dyskinesia, and the role of dopamine metabolism-related genes like COMT in antipsychotic response. The lab also conducts rigorous validation of psychiatric rating scales, such as the MADRS and EPDS, to ensure reliable assessment in Japanese populations.
Figures are computed from collected data and may differ slightly.
Psychotropic dose equivalence is an important concept when estimating the approximate psychotropic doses patients receive, and deciding on the approximate titration dose when switching from one psychotropic agent to another. It is also useful from a research viewpoint when defining and extracting specific subgroups of subjects. Unification of various agents into a single standard agent facilitates easier analytical comparisons. On the basis of differences in psychopharmacological prescription fe
The results suggest that the GABA receptor signaling pathway may be involved in genetic susceptibility to treatment-resistant TD, at least in a subgroup of Japanese patients with schizophrenia. The present results suggest that benzodiazepines may be considered as possible treatment option for TD.
Catechol-O-methyltransferase (COMT) plays a crucial role in the regulation of central dopaminergic systems. We examined the allelic association of a functional polymorphism of the COMT gene with the clinical manifestations and the response to antipsychotics of 100 schizophrenic patients and 201 healthy controls from the general Japanese population. No statistically significant difference was observed in the allele and genotype frequencies between the schizophrenic patients and the healthy contro
The superiority of olanzapine to haloperidol with respect to a decreased incidence of treatment-emergent extrapyramidal syndromes (EPS) in patients with schizophrenia was demonstrated in studies conducted in both Japan and Western countries. EPS measurements used in Western countries included the Simpson-Angus, Barnes akathisia and the Abnormal Involuntary Movement Scale, while the Drug-Induced Extrapyramidal Symptom Scale (DIEPSS) was used in Japan. The aim of this study was to clarify how the
Early detection of perinatal depression is an urgent issue. Our study aimed to examine the construct validity and factor structure of the Japanese version of the Edinburgh Postnatal Depression Scale (EPDS) from a prospective cohort study from pregnancy to postpartum. A total of 1075 women completed all items of the EPDS at four time points: early pregnancy, late pregnancy, 5 days postpartum and 1 month postpartum. The participants were randomly divided into two sample sets. The first sample set
The inter-rater reliability of the Japanese version of MADRS (MADRSJ) was examined using the structured interview guide for MADRS (SIGMA) developed by our group. Two or more psychiatrists attended the systematic interview sessions with each subject to evaluate MADRSJ independently, using SIGMA. A total of 18 interviews was carried out for seven patients with DSM-IV major depressive disorder. The severity of each item assessed by the raters ranged from 0 to 6 for nine items and from 0 to 4 for on
Open papers in the app to read, cite, and organize with AI.